495 related articles for article (PubMed ID: 16344514)
1. Serum antibodies in epilepsy and seizure-associated disorders.
McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to voltage-gated potassium and calcium channels in epilepsy.
Majoie HJ; de Baets M; Renier W; Lang B; Vincent A
Epilepsy Res; 2006 Oct; 71(2-3):135-41. PubMed ID: 16870397
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and epilepsy.
Bien CG; Scheffer IE
Epilepsia; 2011 May; 52 Suppl 3():18-22. PubMed ID: 21542841
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
5. Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.
Liimatainen S; Peltola J; Hietaharju A; Sabater L; Lang B
Epilepsy Res; 2014 Mar; 108(3):592-6. PubMed ID: 24447612
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in patients with gut motility disorders and enteric neuropathy.
Törnblom H; Lang B; Clover L; Knowles CH; Vincent A; Lindberg G
Scand J Gastroenterol; 2007 Nov; 42(11):1289-93. PubMed ID: 17918010
[TBL] [Abstract][Full Text] [Related]
7. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune epilepsy].
Seeck M; Zacharia A; Rossetti AO
Rev Med Suisse; 2010 May; 6(247):925-9. PubMed ID: 20499581
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy.
Liimatainen S; Peltola M; Sabater L; Fallah M; Kharazmi E; Haapala AM; Dastidar P; Knip M; Saiz A; Peltola J
Epilepsia; 2010 May; 51(5):760-7. PubMed ID: 19817821
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
[No Abstract] [Full Text] [Related]
11. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.
Niehusmann P; Dalmau J; Rudlowski C; Vincent A; Elger CE; Rossi JE; Bien CG
Arch Neurol; 2009 Apr; 66(4):458-64. PubMed ID: 19364930
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients.
Errichiello L; Perruolo G; Pascarella A; Formisano P; Minetti C; Striano S; Zara F; Striano P
J Neuroimmunol; 2009 Jun; 211(1-2):120-3. PubMed ID: 19428124
[TBL] [Abstract][Full Text] [Related]
14. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings.
Baysal-Kirac L; Tuzun E; Erdag E; Ulusoy C; Vanli-Yavuz EN; Ekizoglu E; Peach S; Sezgin M; Bebek N; Gurses C; Gokyigit A; Vincent A; Baykan B
J Neurol; 2016 Mar; 263(3):455-66. PubMed ID: 26725084
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune epilepsies.
Irani SR; Bien CG; Lang B
Curr Opin Neurol; 2011 Apr; 24(2):146-53. PubMed ID: 21358545
[TBL] [Abstract][Full Text] [Related]
16. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
17. Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab).
Vianello M; Giometto B; Vassanelli S; Canato M; Betterle C; Mucignat C
Exp Neurol; 2006 Dec; 202(2):514-8. PubMed ID: 16890938
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
19. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
[TBL] [Abstract][Full Text] [Related]
20. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
